Stem Cells for Multiple Sclerosis

According to a population-based estimate (2019), 300,000 to 400,000 individuals are affected by multiple sclerosis (MS): the most common progressive neurologic disease in the United States. The major goals of the research are to target the inflammation and hence protect the nervous system. MSCs isolated from the bone marrow were administered into 15 patients with intrathecally/intravenously.